IRIS
RICCIARDI, Luisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.751
NA - Nord America 8.433
AS - Asia 5.120
SA - Sud America 1.910
AF - Africa 160
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 12
AN - Antartide 1
Totale 26.420
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.264
RU - Federazione Russa 4.760
SG - Singapore 2.436
BR - Brasile 1.633
IT - Italia 1.469
CN - Cina 1.229
IE - Irlanda 1.127
SE - Svezia 1.034
DE - Germania 579
HK - Hong Kong 572
UA - Ucraina 546
FR - Francia 357
FI - Finlandia 282
VN - Vietnam 249
GB - Regno Unito 214
IN - India 143
PL - Polonia 89
AR - Argentina 84
CA - Canada 79
BD - Bangladesh 76
NL - Olanda 71
TR - Turchia 61
IQ - Iraq 55
MX - Messico 53
EC - Ecuador 52
AT - Austria 48
ZA - Sudafrica 46
CO - Colombia 41
VE - Venezuela 36
ID - Indonesia 35
MA - Marocco 35
PK - Pakistan 34
BE - Belgio 32
ES - Italia 30
UZ - Uzbekistan 27
JP - Giappone 24
EE - Estonia 22
CL - Cile 18
EG - Egitto 18
AU - Australia 17
AE - Emirati Arabi Uniti 16
CH - Svizzera 16
NZ - Nuova Zelanda 16
AZ - Azerbaigian 14
IL - Israele 14
JO - Giordania 14
KZ - Kazakistan 14
PE - Perù 14
TN - Tunisia 14
PY - Paraguay 13
SA - Arabia Saudita 12
UY - Uruguay 11
CI - Costa d'Avorio 10
KE - Kenya 10
LT - Lituania 10
OM - Oman 10
TH - Thailandia 10
EU - Europa 9
IR - Iran 9
NP - Nepal 9
CZ - Repubblica Ceca 8
DK - Danimarca 8
PH - Filippine 8
PS - Palestinian Territory 8
SN - Senegal 8
DZ - Algeria 7
MY - Malesia 7
PA - Panama 6
AL - Albania 5
BO - Bolivia 5
CR - Costa Rica 5
NI - Nicaragua 5
RO - Romania 5
AM - Armenia 4
GE - Georgia 4
KG - Kirghizistan 4
KR - Corea 4
LV - Lettonia 4
MD - Moldavia 4
NG - Nigeria 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
JM - Giamaica 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BN - Brunei Darussalam 2
GT - Guatemala 2
IM - Isola di Man 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LY - Libia 2
ME - Montenegro 2
MT - Malta 2
NO - Norvegia 2
Totale 26.386
Salva come PNG Salva come JPEG
Città #
Moscow 1.502
Singapore 1.174
Dublin 1.127
Jacksonville 1.040
Dallas 936
Ashburn 932
Chandler 911
Nyköping 570
Hong Kong 568
Beijing 481
San Jose 384
Princeton 220
The Dalles 216
Messina 209
Los Angeles 202
Medford 193
Lauterbourg 185
Cambridge 182
Des Moines 161
Dearborn 153
Buffalo 133
São Paulo 126
Boardman 124
Ann Arbor 108
Ho Chi Minh City 92
Munich 90
New York 83
Warsaw 82
Rome 80
Council Bluffs 79
Milan 70
Redondo Beach 68
Hanoi 54
Woodbridge 54
Tianjin 52
Wilmington 50
Orem 46
Frankfurt am Main 45
Houston 45
Guangzhou 44
Turku 44
Catania 42
Belo Horizonte 40
Bremen 39
Shenyang 37
Seattle 36
Amsterdam 35
Pune 35
Helsinki 34
Lancaster 34
Rio de Janeiro 33
Brussels 32
Chennai 32
Naples 32
Brasília 31
Brooklyn 31
Johannesburg 30
Nanjing 30
Ottawa 30
Santa Clara 30
Jinan 29
Vienna 29
Nuremberg 26
San Francisco 26
Bologna 25
Dhaka 25
London 25
Tashkent 25
Denver 24
Porto Alegre 24
Tokyo 24
San Mateo 23
Lappeenranta 22
Atlanta 21
Baghdad 21
Ankara 20
Curitiba 20
Florence 20
Boston 19
Quito 19
Phoenix 18
Stockholm 18
Guayaquil 17
Montreal 17
Palermo 17
Salvador 17
Shanghai 17
Campinas 16
Chicago 16
Düsseldorf 16
Santo André 16
Verona 16
Mexico City 15
Sorocaba 15
São José dos Campos 15
Fortaleza 14
Leawood 14
Mumbai 14
Ribeirão Preto 14
Auckland 13
Totale 14.340
Salva come PNG Salva come JPEG
Nome #
Allergia ai fagiolini. Descrizione di un caso. 542
Sindrome di Kounis da antibiotici: descrizione di due casi clinici 315
CASI CLINICI DI ALLERGIA DA CONTATTO A NEOMICINA SOLFATO: MODALITÀ DI SENSIBILIZZAZIONE 305
Benralizumab effectiveness in severe eosinophilic asthma and co-presence of bronchiectasis: a “real-world” retrospective study 273
A controlled study on the effectiveness of loratadine in combination with flunisolide in the treatment of nonallergic rhinitis with eosinophilia (NARES) 228
food allergy due to sensitisation to nickel containing foods: hyposentisation is feasible and efficacious 225
Nickel sensitization influence on microbiota in allergic and non-allergic disorders: what's up? 219
Alexithymia in an unconventional sample of Forestry Officers: a Clinical Psychological study with surprising results 194
Impairment of sensory-motor plasticity in mild Alzheimer's disease 193
Aluminium allergy in a patient with occupational contact dermatitis. 191
Allergic response due to a para-amino compound 184
Ipersensibilità agli alimenti: quale ruolo per il nichel introdotto con la dieta? 177
Antistaminici topici e sistemici. 177
Systemic mastocytosis associated with recurrent paroxysmal atrial fibrillation 177
ASSISTENZA ALLA PERSONA CON DISTURBI IMMUNO-MEDIATI 175
Systemic nickel allergy syndrome: tips and tricks on how to be suspected and treated 175
Sembrava solo un caso di orticaria................. 172
Castleman Disease in a Patient with Common Variable Immunodeficiency 171
Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review 171
Allergic Sensitization and Psychosomatic Involvement in Outdoor and Indoor Workers: A Preliminary and Explorative Survey of Motorway Toll Collectors and Office Employees 168
Alexithymia and asthma: a systematic review 168
Latex PPE-induced reactions during the COVID-19 pandemic: gender and previous allergies as distinctive predisposing factors among healthcare workers 167
A controlled study on the effectiveness of loratadine in combination with flunisolide in the treatment of nonallergic rhinitis with eosinophilia (NARES). 166
ALLERGIC CONTACT DERMATITIS AFTER TOPICAL TREATMENT WITH ZINC OXIDE PASTE 166
Does age really infl uence the severity of the reaction to hymenoptera sting? 166
Sindrome orticaria-angioedema da applicazione topica di adapalene 166
Misdiagnosis of celiac disease (CD) and Systemic nickel allergy syndrome (SNAS): which overlaps? 162
Aerobiologia e moderna gestione della sanità pubblica; obiettivi e prospettive 161
Adverse reactions to glatimer: allergic or pseudoallergic? 161
Is atopy a predisposing factor for developing Hymenoptera venom allergy? 159
Allergic contact dermatitis to nebivolol 158
La pollinosi da Corylaceae in un comune sub-montano del messinese. 156
Adherence to omalizumab: A multicenter "real-world" study 155
Sembrava solo un caso di orticaria 152
I nuovi antistaminici. 151
OSSERVAZIONI SUL DOSAGGIO DI AUTOANTICORPI ANTI-TIROIDEI 150
Adverse reactions to pantoprazole 150
Hymenoptera venom immunotherapy: a lifesaving tratment inducing IgE modifications in real life polysensitized subjects 148
Allergia agli anestetici generali: casistica personale. 148
Occupational asthma in wood workers 147
ASSOCIAZIONE TRA ORTICARIA CRONICA E TIREOPATIA AUTOIMMUNE 146
Adverse reaction to interferon-beta 1a: case report 145
Allergic rhinitis: the eligible candidate to mite immunotherapy in the real world 145
Local anaesthetics (LA) allergy: which is the truth? 144
Allergia al veleno di imenotteri e atopia: valutazione retrospettiva della nostra casistica. 143
Burning mouth syndrome due to cadmium in a denture wearer 143
Comparative study between fluticasone propionate and cetirizine in the treatment of allergic rhinitis 143
Hymenoptera venom immunotherapy: a lifesaving treatment inducing ige modifications in real life polysensitized subjects 142
Cutaneous amebiasis in an Iranian immunodeficient alcoholic: Immunochemical and histological study 142
Omalizumab: A useful tool for inducing tolerance to Bee Venom Immunotherapy 142
Systemic nickel allergy: oral desensitization and possible role of cytokines interleukins 2 and 10 142
Antihistamine therapy in urticaria 141
Characteristics and treatment regimens across ERS SHARP severe asthma registries 141
Effect of fluticasone propionate on interleukin-12 and interferon-gamma production in patients affected by allergic bronchial asthma 137
Drug induced kounis syndrome: does oxidative stress play a role? 136
Intolleranza al lattosio e allergia all'aspergillus: quale correlazione? 136
Serum levels of protein oxidation products in patients with nickel allergy. 136
Progesterone adverse reaction: a case report 136
Omalizumab in chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response. 136
Caratterizzazione delle reazioni avverse a farmaci segnalate da un reparto di Allergologia e Immunologia Clinica 135
Omalizumab in middle-aged or older patients with severe allergic asthma-COPD overlap 135
Follow-up of hymenoptera allergic patients who dicontinue venom immunotherapy 134
ANAPHYLACTIC SHOCK CAUSED BY ANISAKIS SIMPLEX 133
Treatmentn of non-IgE-mediated food hypersensitivity reactions due to nickel 133
ASMA ALLERGICO SEVERO IN TRATTAMENTO CON OMALIZUMAB: RISULTATI IN TERMINI DI QUALITA’ DI VITA 133
Probiotic supplementation in systemic nickel allergy syndrome patients: study of its effects on lactic acid bacteria population and on clinical symptoms 130
Clinical Psychology and Clinical Immunology: is there a link between Alexithymia and severe Asthma? 129
Gluten-related disorders: certainties, questions and doubts 129
CROSS-REACTIVITY BETWEEN PARIETARIA POLLEN AND MULBERRY FRUIT 127
Urticaria induced by exposur to mussels vapours in a nickel allergic patient 126
Allergen immunotherapy may exert an extra-anti-allergic activity in children. 126
Insect sting anaphylaxis with documented IgE allergy 123
Urticaria in a tattooed patient 120
Ruolo degli acari della polvere nel determinismo di patologie respiratorie perenni 119
Severe allergic asthma: Does alexithymia interfere with omalizumab treatment outcome? 119
Allergen Sublingual Tablet Immunotherapy: Is it Possible to Induce nsLTPs Tolerance? 118
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments 118
A survey on features of allergic rhinitis in children 117
Difficoltà di inquadramento eziopatologico della Sindrome Orticaria-Angioedema 116
Burning mouth syndrome: Hypersensitivity to sodium metabisulfite 116
Sistema Immunitario: generalità e accertamento 116
Plant Food Allergy Improvement after Grass Pollen Sublingual Immunotherapy:A Case Series 114
H1-Antihistamines for Allergic Diseases: Old Aged but Not Old-Fashioned Drugs 113
CONGIUNTIVITE ALLERGICA PERENNE DA ACARI DELLA POLVERE. 113
The role of nickel in foods exacerbating nickel contact dermatitis 113
Case Report: Severe Eosinophilic Asthma Associated With ANCA-Negative EGPA in a Young Adult Successfully Treated With Benralizumab 112
La ciprofloxacina nel trattamento delle riacutizzazioni della broncopneumopatia cronica ostruttiva (BPCO). 112
New therapeutic approaches in atopic dermatitis. 112
Difficoltà di inquadramento etiopatogenetico della sindrome orticaria-angioedema (casistica personale). 111
Olea sublingual allergoid immunotherapy administered with two different treatment regimens 111
REAL LIFE EXPERIENCE WITH OMALIZUMAB IN TREATING PATIENTS WITH POORLY CONTROLLED MODERATE TO SEVERE ALLERGIC ASTHMA 111
Hymenoptera Venom Allergy: Management of children and adults in clinical practice 111
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 111
TRATTAMENTO DELL’ASMA DI DIFFICILE CONTROLLO CON OMALIZUMAB: NOSTRA ESPERIENZA. 109
Is systemic nickel allergy syndrome (SNAS) a form of non-IgE mediated food hypersensitivity? 106
Trattamento iposensibilizzante orale con nichel solfato: efficacia e sicurezza. 106
Omalizumab: A useful tool for inducing tolerance to bee venom immunotherapy 105
LA POLLIOSI DA PARIETARIA IN ITALIA 104
Alterazioni della mucosa gastroduodenale e reazioni avverse ad alimenti 104
I NUOVI ANTISTAMINICI 104
Totale 15.099
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.917
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 0 0 0 0 0 0 53
2021/20221.295 18 124 35 31 40 9 64 53 29 234 174 484
2022/20233.568 298 254 173 311 320 368 46 226 1.405 34 100 33
2023/2024914 79 142 59 93 95 140 23 77 11 45 56 94
2024/20254.773 77 73 98 285 395 105 94 1.062 1.167 240 412 765
2025/202611.752 534 914 935 765 968 2.596 1.458 1.330 1.328 520 305 99
Totale 26.766